Answer
Cimzia (certolizumab pegol) is contraindicated in moderate to severe heart failure (NYHA classes III/IV).
Sources for this answer
- Cimzia 200 mg solution for injection in pre-filled syringeUCB Pharma Limited · emc · SmPC §4.3 Contraindications · Version 34Document updated
Sources checked